Thomas Jerome Lynch - 14 Feb 2021 Form 4 Insider Report for MedMen Enterprises, Inc.

Reporting relationship: CEO
Issuer ticker: N/A
Reported as of: 14 Feb 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Oct 2021, 19:34:52 UTC
Prior SEC filing: 05 Oct 2021
Source filing: View source filing
Reporting owner signature: /s/ Thomas Jerome Lynch

Key filing fact

Thomas Jerome Lynch filed Form 4 for MedMen Enterprises, Inc. on 05 Oct 2021.

Key facts

This page summarizes Thomas Jerome Lynch's Form 4 filing for MedMen Enterprises, Inc..
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Oct 2021, 19:34.

Change

Previous filing in this sequence was filed on 05 Oct 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MMNFF transaction

Class B Subordinate Voting Shares

Award

Transaction value: $0
Shares: +1,258,322
Change %: +258%
Price: $0.000000
Shares after: 1,746,135
Date: 14 Feb 2021
Ownership: Direct
Footnotes: F1, F2

MMNFF transaction

Class B Subordinate Voting Shares

Award

Transaction value: $0
Shares: +850,036
Change %: +49%
Price: $0.000000
Shares after: 2,596,171
Date: 29 Aug 2021
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MMNFF transaction Derivative

Employee Stock Options (right to buy)

Award

Transaction value: $0
Shares: +214,030
Change %
Price: $0.000000
Shares after: 214,030
Date: 29 Aug 2021
Ownership: Direct
Underlying class: Class B Subordinate Voting Shares
Underlying amount: 214,030
Exercise price: $0.2814
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Issued pursuant to Issuer's 2018 Stock Incentive Plan.

Footnote F2

Represents restricted stock units ("RSUs"), which vest annually over four years beginning 6/30/2021, with 37.5% of shares vesting on 6/30/2021 and 6/30/2023, and 12.5% of shares vesting on 6/30/2022 and 6/30/2024. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of such shares of Issuer.

Footnote F3

Represents RSUs, which vest annually over four years beginning 6/30/2022, with 37.5% of shares vesting on 6/30/2022 and 6/30/2024, and 12.5% of shares vesting on 6/30/2023 and 6/30/2025. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of such shares of Issuer.

Footnote F4

Such options have an exercise price of CAN$0.355, which is equivalent to US$0.2814 at an exchange rate of 1.2635.